Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Items 401–500 of 563
Diagnosis, Complications and Treatment of Paget’s Disease of Bone
Seton, M. (2009) · Aging Health · doi:10.2217/ahe.09.39 · Cited by 6
Behnam, K., Murray, S. S., & Brochmann, E. J. (2005) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2004.12.012 · Cited by 6
Latest developments in Paget's disease of bone
Ralston, S. H. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf202 · Cited by 7
Sporadic Paget's disease of the bone. Case series and literature review
Caicedo, A. I. O., Escobar, V. E. G., Urrea, V. A. C., Charry, J. S. S., & Izquierdo, J. H. (2020) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2020.06.002 · Cited by 7
Sequestosome 1/p62: a multi-domain protein with multi-faceted functions
Liu, X., Gál, J., & Zhu, H. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1217-z · Cited by 5
“, 2003), P392L (Hocking et al., 2002; Laurin et al., 2002), L394X (Hocking et al.”
InfluentialArvaniti, K., Papadioti, A., Kinigopoulou, M., Theodorou, V., Skobridis, K., & Tsiotis, G. (2014) · Proteomes · doi:10.3390/proteomes2030363 · Cited by 5
“In the first experiment, the sequestosome-1 protein, which is involved in cell differentiation, apoptosis, immune response and bone diseases [43–45], was not affected by the different drugs treatments.”
BackgroundAux origines de la maladie osseuse de Paget. Un nouveau cas néolithique dans le sud de la France
Arnautou, J.-P., Blondiaux, J., Coindre, J., & Duday, H. (2011) · Bulletins et Mémoires de la Société d anthropologie de Paris · doi:10.1007/s13219-010-0031-x · Cited by 5
“[3] ont mis en évidence des mutations géniques chez les malades pagétiques, dans des proportions variables suivant les populations ; d’autres études comme celle de Baslé [4], parfois controversées, ont incriminé plusieurs virus de la famille des paramyxovirus.”
BackgroundWhere is bone science taking us?
Langdahl, B. L., Uitterlinden, A. G., & Ralston, S. H. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101791 · Cited by 6
EBAG9-deficient mice display decreased bone mineral density with suppressed autophagy
Azuma, K., Ikeda, K., Shiba, S., Sato, W., Horie, K., Hasegawa, T., Amizuka, N., Tanaka, S., & Inoue, S. (2024) · iScience · doi:10.1016/j.isci.2024.108871 · Cited by 5
“21 The missense mutation of p62 was shown to be associated with Paget’s disease of bone, 25 a disorder caused by abnormally increased and disorganized bone turnover.”
BackgroundIntricacies of aetiology in intrafamilial degenerative disease
Lowry, J., Ryan, É. B., Esengul, Y. T., Siddique, N., & Siddique, T. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa120 · Cited by 5
“SQSTM1 is a known pleiotropic gene given that it is implicated in multiple degenerative diseases, including ALS, FTD, ALS/FTD, vacuolar myopathy and Paget disease of bone (Laurin et al., 2002; Fecto, 2011; Bucelli et al., 2015).”
BackgroundStratified medicine approaches for the treatment of musculoskeletal disorders
Hocking, L. J., & Rivadeneira, F. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.05.003 · Cited by 6
Infiltrating giant cell tumor in a case of Paget’s disease of bone
Nuzzo, V., Ferrara, T., Zuccoli, A., Brunetti‐Pierri, R., Rosa, R. D., Falchetti, A., Franco, R., & Brunetti‐Pierri, N. (2009) · Archives of Osteoporosis · doi:10.1007/s11657-009-0027-7 · Cited by 5
“The most important gene for PDB is Sequestosome 1 (SQSTM1/p62) encoding a protein implicated in pre-osteoclast recruitment and maturation and a molecular partner of the NFκBsignaling pathway [2].”
Tsuruga, E., Rao, D. S., Baatz, J. E., & Reddy, S. V. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20874 · Cited by 5
“Recurrent mutations in the ubiquitin-associated domain of Sequestosome 1 (SQSTM1/p62) are identified in patients with PD [Laurin et al., 2002; Johnson-Pais et al., 2003; Hocking et al., 2004].”
BackgroundCell–Cell and Cell–Matrix Interactions in Bone
Bonewald, L. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00313-2 · Cited by 6
Hogendoorn, P. C. W., Bovée, J. V. M. G., Karperien, M., & Cleton-Jansen, A. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005996 · Cited by 5
Scarfò, F., Brunetto, E., Magliacane, G., Pecciarini, L., Ferrara, G., & Rizzo, N. (2025) · Journal of Cutaneous Pathology · doi:10.1111/cup.14798 · Cited by 4
Corral-Gudino, L. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.05.010 · Cited by 8
Del, A., & Teti, A. M. (2011) · InTech eBooks · doi:10.5772/23417 · Cited by 4
“The first mutation identified in French pagetic patients was the Proline-Leucine mutation affecting codon 392 (P392L) in the UBA domain (Laurin et al., 2002).”
Paria, N., Copley, L. A., Herring, J. A., Kim, H. K. W., Richards, B. S., Sucato, D. J., Rios, J. J., & Wise, C. A. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.m.00398 · Cited by 4
Gene Expression Profiles of Mesenchymal Stem Cells
Phinney, D. G. (2006) · Springer eBooks · doi:10.1007/1-4020-3959-x_3 · Cited by 4
Huybrechts, Y., Ridder, R. D., Steenackers, E., Devogelaer, J., Mortier, G. R., Hendrickx, G., & Hul, W. V. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01137-5 · Cited by 4
“With regard to the latter, the SQSTM1 gene, coding for the p62 protein, has been described as a major genetic factor, as heterozygous pathogenic variants were found in 25–40% of patients with a family history and in up to 10% of sporadic cases [5–8].”
BackgroundCan zebrafish be a valid model to study Paget's disease of bone?
Silva, I. A. L., Conceição, N., Michou, L., & Cancela, M. L. (2014) · Journal of Applied Ichthyology · doi:10.1111/jai.12523 · Cited by 5
Exclusion of TNFRSF11B as Candidate Gene for Otosclerosis in Campania Population
Iossa, S., Morello, G., Esposito, T., Corvino, V., Giannini, P., Salvato, R., Cavaliere, M., Panetti, M., Panetti, G., Piantedosi, B., et al. (2014) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-014-0706-6 · Cited by 4
Langston, A. L., Johnston, M., Francis, J., Robertson, C., Campbell, M., Entwistle, V. A., Marteau, T. M., MacLennan, G., Weinman, J. A., McCallum, M., et al. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-116 · Cited by 5
“dian population where 50% of familial PDB patients and 20% of "sporadic" patients have SQSTM1 mutations [9].”
BackgroundInfluentialLessard, S., Chao, M. J., Reis, K., Beauvais, M., Rajpal, D. K., Shankara, S., Sloane, J., Palta, P., Klinger, K. W., de Rinaldis, E., et al. (2023) · medRxiv · doi:10.1101/2023.11.01.23297926 · Cited by 4
Sidibe, D. K., Smith, E. M., Spivey, M. L., Vogel, M. C., & Maday, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345890 · Cited by 5
Corral-Gudino, L. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.05.005 · Cited by 9
Masuko, S., Sato, M., Nakamura, K., Hamanaka, K., Miyatake, S., Inaba, Y., Kosho, T., Matsumoto, N., & Sekijima, Y. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70044 · Cited by 3
“Heterozygous variants of the SQSTM1 - encoded gene ( SQSTM1 ) have been reported in patients with Paget disease of the bone (Laurin et al. 2002), amyotrophic lateral sclerosis, and/or frontotemporal dementia (Hirano et al. 2013), and distal myopathy with rimmed vacuoles (Bucelli et al. 2015).”
Paget’s disease of bone: epidemiology, pathogenesis and pharmacotherapy
Gennari, L., Merlotti, D., Rendina, D., Gianfrancesco, F., Esposito, T., & Nuti, R. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.904225 · Cited by 4
“In fact, although a single mutation (P392L) has been observed in FrenchCanadian population, a particularly higher heterogeneity of SQSTM1 mutations has been detected in Italian population, with up to 13 different mutations [59,62,63].”
BackgroundInfluentialSinger, F. R., & Roodman, G. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00067-1 · Cited by 4
Sclerosing bone disorders: a lot of knowns but still some unknowns
Hul, W. V. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.97 · Cited by 3
Hereditary Disorders of the Skeleton
Whyte, M. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00068-8 · Cited by 4
Genomewide Screens in Ankylosing Spondylitis
Brown, M. A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0298-6_11 · Cited by 3
Komatsu, M., Koike, M., Ichimura, Y., & Uchiyama, Y. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814350457_0008 · Cited by 4
Fishlock, A., & Patel, N. (2018) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2018.05.009 · Cited by 3
Basic Aspects of Osteoclast Differentiation and Function
Alesi, N., Charles, J. F., & Nakamura, M. C. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_2 · Cited by 6
SQSTM1 gene as a potential genetic modifier of CADASIL phenotype
Almeida, M. R., Silva, A. R., Elias, I., Fernandes, C., Machado, R., Galego, O., & Cordeiro, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10308-5 · Cited by 3
Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research
Fan, P., Wang, N., Wang, L., & Xie, X. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666190206122149 · Cited by 3
Genotype–phenotype correlation of SQSTM1 variants in patients with amyotrophic lateral sclerosis
Wang, S., Jiang, Q., Zheng, X., Wei, Q., Lin, J., Yang, T., Xiao, Y., Li, C., & Shang, H. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109569 · Cited by 4
“Besides ALS, cognitive and neuropsychiatric symptoms, our patients with ALS with SQSTM1 variants did not present with other neurological symptoms such as ataxia, parkinsonism or Paget’s disease of bone (PDB).”
InfluentialJeong, H. S., Lee, S. K., Kim, J.-Y., Yoo, C., & Joo, M. W. (2025) · Diagnostics · doi:10.3390/diagnostics15243120 · Cited by 2
“Additional TP53 mutations or MDM2 amplification may drive sarcomatous transformation in advanced disease [58,59].”
Rabjohns, E. M., Rampersad, R. R., Ghosh, A., Hurst, K., Eudy, A. M., Brozowski, J. M., Lee, H. H., Ren, Y., Mirando, A. J., Gladman, J. T., et al. (2023) · Cells · doi:10.3390/cells12070981 · Cited by 2
“In 2002, mutations in the SQSTM1 gene were identified as being causative in a proportion of adult-onset PDB cases [4].”
BackgroundAlginate Nanofiber Scaffolds for Amyotrophic Lateral Sclerosis
Maulding, D. M., Bielanin, J., Cole, P., Tian, Y., Saeeidi, M., Sharma, H. S., Sharma, A., & Tian, R. (2024) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-49744-5_9 · Cited by 2
Uto, H. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00585.x · Cited by 2
Morbus Paget des Knochens – eine aktuelle Übersicht zu Klinik, Diagnostik und Therapie
Klemm, P., Dischereit, G., von Gerlach, S., & Lange, U. (2020) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-020-00897-x · Cited by 2
The Development of Drug Therapies for Frontotemporal Dementia Caused by Progranulin Mutations
Muynck, L. D., & Damme, P. V. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681080680115030007 · Cited by 2
“Mutations in SQSTM1 had previously been associated with Paget’s disease of bone (PDB) [85, 86].”
BackgroundRepublished: Paget’s disease of bone: clinical review and update
Bolland, M. J., & Cundy, T. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-201688rep · Cited by 5
The Molecular Basis of Sarcoma
Lessnick, S. L., Kovar, H., & Houghton, P. J. (2011) · Sarcoma · doi:10.1155/2011/864130 · Cited by 3
La maladie osseuse de Paget, une condition évanescente ?
Guay-Bélanger, S., Cormier, J.-G., & Michou, L. (2015) · Revue du Rhumatisme · doi:10.1016/j.rhum.2014.10.006 · Cited by 7
Progress in RANK ligand biology: bone and beyond
Andrews, N. A. (2012) · IBMS BoneKEy · doi:10.1038/bonekey.2012.93 · Cited by 4
The role of genes in the pathogenesis of Paget's disease of bone
Chung, P. Y. J., & Hul, W. V. (2010) · IBMS BoneKEy · doi:10.1138/20100436 · Cited by 2
Seton, M., & Krane, S. M. (2009) · Springer eBooks · doi:10.1007/978-1-84800-934-9_41 · Cited by 2
“This mutation results in a C→ T transition mutation (P392L) that in turn results in aberrant osteoclast activation (Laurin et al. 2002).”
BackgroundTwo siblings with Paget's disease of bone
Naik, D., Asha, H. S., Mathews, S. S., & Paul, T. V. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-203219 · Cited by 2
Ridder, R. D., Vandeweyer, G., Boudin, E., Hendrickx, G., Huybrechts, Y., Cremers, T. C., Devogelaer, J., Mortier, G. R., Fransén, E., & Hul, W. V. (2021) · Calcified Tissue International · doi:10.1007/s00223-021-00881-w · Cited by 3
Endocrinology of Bone and Growth Disorders
Farquharson, C., Stephen, L. A., & Wong, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00086-4 · Cited by 3
Lin, Z., Ibrahim, A. N., Brown, R. H., & Sreedharan, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00034-0 · Cited by 2
Molecular Genetics of Paget's Disease of Bone
Gennari, L., Gianfrancesco, F., Rendina, D., & Merlotti, D. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0024396 · Cited by 2
Klinik und Diagnose des Morbus Paget
Mikosch, P., Trifina-Mikosch, E., Roschger, P., Haller, J. M., & Klaushofer, K. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Genetic aspects of the Paget’s disease of bone
Falchetti, A., Stefano, M. D., Marini, F., Ortolani, S., Ulivieri, M. F., Bergui, S., Masi, L., Cepollaro, C., Benucci, M., Munno, O. D., et al. (2012) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) · doi:10.13140/rg.2.1.2290.9681 · Cited by 2
Mutations in Osteoclast Genes as Causes of Osteoclast-Related Diseases
Živković, J. M., Najdanović, J. G., & Najman, S. J. (2025) · DNA and Cell Biology · doi:10.1177/10445498251368298 · Cited by 1
“The SQSTM1 encodes a protein termed p62 (Laurin et al., 2002), with an important role in bone remodeling.”
Michou, L., & Brown, J. P. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2564667 · Cited by 3
“Additionally, no correlation was found between the heterozygous p.Pro392Leu missense variant and the age at PDB diagnosis or the number of affected bones [71,76].”
InfluentialSelf-citationFrom bone alterations to tumours: Genetic drivers linking Paget’s disease of bone to cancer
Gianfrancesco, F., & di Carlo, F. S. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105387 · Cited by 1
Colbert, R. A. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.028 · Cited by 1
Hoff, A. O., & Novis, Y. A. S. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2166 · Cited by 1
Protective Roles of Nrf2 in Disease including Oral Disease
Yanagawa, T., Itoh, K., & Ishii, T. (2005) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(05)80020-9 · Cited by 1
Monostotic Paget's disease of the calcaneus: A rare location
Moratalla, M. B., Gabarda, R. F., & Nebot, M. J. S. (2007) · European Journal of Radiology Extra · doi:10.1016/j.ejrex.2007.10.002 · Cited by 1
Meeting report from the 26th annual meeting of the American society for bone and mineral research
Bouillon, R., Klein, R. F., Jiang, Y., Petit, M. A., Seeman, E., Ducy, P. F., Reszka, A. A., Bikle, D. D., Schipani, E., Strewler, G. J., et al. (2004) · BoneKEy-Osteovision · doi:10.1138/20040139 · Cited by 1
Audran, M., Sutter, B., & Chappard, D. (2015) · Cited by 1
Paget’s Disease of the Bone: A Case Report
Özer, M., Erol, A. M., & Çelik, C. (2015) · Turkish Journal of Osteoporosis · doi:10.4274/tod.75046 · Cited by 1
Einarsson, H. B., Mikkelsen, R., Gylfason, J. T., & Lützhøft, J. H. (2019) · Læknablaðið · doi:10.17992/lbl.2019.05.231 · Cited by 2
Enfermedad de Paget de hueso esporádica. Serie de casos y revisión de la literatura
Caicedo, A. I. O., Escobar, V. E. G., Urrea, V. A. C., Charry, J. S. S., & Izquierdo, J. H. (2019) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2019.07.004 · Cited by 3
Singer, F. R., & Roodman, G. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00081-1 · Cited by 1
Singer, F. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00072-x · Cited by 1
Velasco, S. L., Arteche‐López, A., Méndez-Guerrero, A., Puertas‐Martín, V., Quesada‐Espinosa, J. F., Rosales, J. M. L., González‐Sánchez, M., Blanco-Palmero, V. A., Milla, C. P., Martín, A. H. S., et al. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1927101 · Cited by 2
“The aim of this review was to describe the main features of SQSTM1-related FTD cases: family history, clinical phenotype, presence of PDB or previous psychiatric disorder, neuroimaging pattern, and types of variants in the SQSTM1 gene.”
BackgroundInfluentialGenetics of Paget’s Disease of Bone
Albagha, O., & Ralston, S. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805083-5.00003-8 · Cited by 3
Paget’s Disease of Bone: Pathogenesis and Treatment
Singer, F. R., & Roodman, G. D. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_12 · Cited by 2
“Of the numerous mutations found in the sequestosome 1/p62 gene, the p62 P392L was the most common [ 56, 81, 88 ] .”
BackgroundResultMolecular test of Paget's disease of bone in families not linked to SQSTM1 gene mutations
You, Y., Simonyan, D., Bureau, A., Gagnon, É., Albert, C., Guertin, J. R., Tarride, J., Brown, J. P., & Michou, L. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101670 · Cited by 1
Self-citationDiagnosis and treatment of Paget´s disease of bone: update 2020
Zikán, V. (2020) · Clinical Osteology · doi:10.36290/clo.2020.024 · Cited by 1
To Degrade or not to Degrade : Protein Handling by the Proteasome
Heinen, C. (2010) · Figshare · Cited by 1
Sunumu, O., Bozdağ, K. E., Altun, Y., & Ermete, M. (2004) · Cited by 1
Osteoporosis and metabolic bone disease
(2014) · Rheumatology · doi:10.1093/rheumatology/keu113 · Cited by 1
Osteoclasts in Skeletal Diseases
Sun, Q., Adamik, J., & Galson, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11168-7 · Cited by 1
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Zack, D. J., & Feige, U. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_10
Preoperative Management of Paget’s Disease
Tucci, J. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-19905-4_9
SQSTM1 mutations and Paget's disease of bone
Najat, D. (2010) · Nottingham ePrints (University of Nottingham)
Reddy, S. V. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00967-7
Pharmacotherapy of Paget's Disease of Bone: Focus on Zoledronic Acid
Τζιόμαλος, Κ., Athyros, V. G., & Karagiannis, A. I. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s1095
Paget’s disease: clinical update
Donáth, J., & Poór, G. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29174
Liu, X. (2012) · UKnowledge (University of Kentucky) · Cited by 1
Cornish, J., Kronenberg, H. M., Rogers, M. J., Papapoulos, S. E., & Mundy, G. R. (2006) · BoneKEy-Osteovision · doi:10.1138/20060195
Nuove acquisizioni patogenetiche e terapeutiche ella malattia ossea di Paget
Gennari, L., & Merlotti, D. (2013) · L Endocrinologo · doi:10.1007/bf03346067
“Le mutazioni che interessano il gene del sequestosoma 1 (SQSTM1) rappresentano attualmente la causa maggiore di malattia ossea di Paget e sono state descritte circa nel 2540% dei casi familiari e nel 5-15% dei casi sporadici in diverse casistiche di pazienti (3, 10).”
BackgroundÉtude épidémiogénétique de familles françaises avec maladie osseuse de Paget
Michou, L., Collet, C., Morissette, J., Audran, M., Thomas, T., Gagnon, É., Launay, J., Laplanche, J., Brown, J. P., & Orcel, P. (2011) · Revue du Rhumatisme · doi:10.1016/j.rhum.2011.07.007
Self-citationCundy, T. (2004) · BoneKEy-Osteovision · doi:10.1138/20040125
Génétique de la maladie de Paget
Michou, L., Collet, C., Laplanche, J., Orcel, P., & Cornélis, F. (2006) · Revue du Rhumatisme · doi:10.1016/j.rhum.2005.05.015 · Cited by 1
The Genetic Variations of SQSTM1 Gene are Associated with Bone Density in the Korean Population
Jin, H., & Eom, Y. (2010) · Journal of Life Science · doi:10.5352/jls.2010.20.12.1758
“found a Proline-Leucine mutation affecting codon 392 (P392L) in the ubiquitin-associated (UBA) domain of the SQSTM1 protein an important cause of PDB in French Canadians [8].”
BackgroundInfluentialEslava, A. T. (2014) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2014000400001 · Cited by 4
Pathogenesis of Paget’s disease of bone
Kurihara, N., & Roodman, G. D. (2004) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
Genetics of Paget's disease of bone-like disorders
Gavin, J. A. L., & Ralston, S. H. (2004) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)
Reddy, S. V. (2006) · Defense Technical Information Center (DTIC) · doi:10.21236/ada462833
GENETSKI DEJAVNIKI V POVEZAVI Z AMIOTROFIČNO LATERALNO SKLEROZO
Vrabec, K., & Ravnik‐Glavač, M. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1275
Audran, M., Sutter, B., & Chappard, D. (2016) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(15)76104-6
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.